Company Filing History:
8 out of 13 
3 out of 3 
2 out of 2 Years Active: 2013-2025
Title: Innovator Huamao Wang: A Pioneer in Tumor Treatment
Introduction
Huamao Wang, based in Shanghai, China, is a renowned inventor with a remarkable portfolio of 18 patents. His innovative work primarily focuses on the development of advanced treatments for tumors and related medical applications. With a solid background in medical research, Wang continues to be an influential figure in the field of biotechnology.
Latest Patents
Among his latest contributions are two significant patents. The first, titled "Method and Composition for Treating Tumors," presents a comprehensive treatment kit that includes a composition of immune effector cells. This invention emphasizes the importance of both initial and subsequent doses of immune effector cells to enhance treatment efficacy. The second patent, "Antibody Against Glypican-3 and Application Thereof," details the development of an antibody targeting glypican-3 (GPC3), including designs for a single-chain antibody and a humanized antibody, which have potential therapeutic applications.
Career Highlights
Over the years, Huamao Wang has been associated with notable companies, including Crage Medical Co., Limited and Carsgen Therapeutics Co., Ltd. His work within these organizations has not only facilitated the clinical application of his inventions but has also positioned him as a leader in innovative cancer therapies.
Collaborations
Throughout his career, Wang has collaborated with esteemed colleagues, including Zonghai Li and Bo Song. These partnerships have fostered a rich environment of innovation and have contributed significantly to his research outcomes and patent applications.
Conclusion
Huamao Wang's substantial contributions to the field of biotechnology demonstrate his commitment to advancing cancer treatment methodologies. With his extensive patent portfolio and collaborative approach, he remains a key player in the research and development of life-saving medical innovations. His ongoing efforts continue to inspire future inventions that could ultimately improve patient outcomes in oncology.